An outbreak of poliomyelitis in Finland resulted in the widespread circulation of wild-type 3 poliovirus strains that had antigenic properties distinct from the strains used to produce the attenuated and inactivated vaccines. Considerable variation was observed in the ability of broadly reacting monoclonal antibodies directed against type 3 poliovirus to neutralize the 54 strains examined. Sequential isolates from several persons showed an antigenic drift with these monoclonal antibodies and selected human sera. In addition, some faecal specimens were found to contain more than one antigenic variant. Primer extension sequencing of genomic RNAs of three plaquepurified antigenic variants isolated from one patient showed base substitutions in the region coding for the major antigenic site of poliovirus type 3. The resulting difference in the amino acid sequence in the virion protein VP1 could explain the differences observed in the neutralization of these strains by the monoclonal antibodies. Whether the observed changes in the antigenic characteristics of the sequential isolates represent true antigenic drift under immunological pressure or whether the emergence of the new variants is based on other modes of selection during replication is not known.
INTRODUCTION
Poliovirus serotypes 1, 2 and 3 have been considered to be relatively stable as regards the antigenic determinants involved in virus neutralization Ferguson et al., 1985) , in spite of the rapid evolution of the genome as shown by oligonucleotide fingerprinting (Nottay et al., 1981) . However, individual isolates have been described that differ antigenically from the reference strains (B6ttiger, 1971 ; Ferguson et al., 1985) , but these isolates have not had recognizable epidemiological significance. More recently, antigenic changes in poliovirus type 3 were detected in consecutive isolates from a vaccinee . Between August 1984 and January 1985 an outbreak of poliomyelitis occurred in Finland after a 20 years interval without a single reported case. Nine paralytic cases occurred and probably more than 100000 individuals were infected . The wild-type poliovirus 3 strains isolated during the outbreak have been shown to differ considerably (Magrath et aL, 1986) in both immunological and molecular properties from the Leon 12a~ b and Saukett strains used in the oral live and in the inactivated poliovirus vaccines, respectively. Such differences may have contributed to the wide dissemination of the virus in the vaccinated population .
In this paper we report further antigenic analysis of the epidemic strains. In addition to demonstrating the considerable antigenic variation between isolates from different individuals 0000-7552 © 1987 SGM infected with the virus, sequential isolates from several persons reveal antigenic changes during the period of virus excretion, suggesting that wild-type poliovirus 3 is capable of antigenic drifting during an outbreak.
METHODS
Virus strains. The strains analysed were isolated from patients with poliomyelitis or healthy contacts of the patients by inoculating continuous monkey kidney cell lines (Vero, GMK, LLC-MK2) or primary human amnion cells with extracts of faecal specimens. The cytopathogenic agents grown were identified as poliovirus type 3 by neutralization with type-specific hyperimmune rabbit sera, and subsequently passaged twice in Vero cells at low multiplicity. Ten strains were obtained from seven patients, including four strains taken at 7 or 14 day intervals from the index case of the outbreak . A further 43 strains were isolated from 32 healthy persons who were either contacts of the index patient or contacts of his virus-excreting contacts.
Microneutralization assay. Antigenic characteristics of the strains were assessed using a microneutralization assay and a panel of monoclonal type 3-specific antibodies (Ferguson et al., 1984; Minor et al., 1985) and polyclonal sera. Fifty to 100 TCIDs0 units virus and 15000 Vero cells were used per microtitre well (Nunc). The results were assessed by microscopy on day 6. The last dilution giving complete inhibition of viral c.p.e, was considered as the endpoint titre.
In addition to the reagents shown in Table 1 we used a hyperimmune rabbit anti-poliovirus type 3/Saukett serum, a pool of human adult sera and an immunoglobulin concentrate prepared from pooled plasma of donated human blood (a gift from the Blood Transfusion Service Laboratory of the Finnish Red Cross, Helsinki, Finland).
Partialsequencing ofvirion RNA. The plaque-purified virus strains were grown in HEp-2 cells, purified in sucrose gradients and the partial sequence of the phenol-extracted RNA was determined by the dideoxy primer extension method as described in detail previously (Evans et al., 1983) .
RESULTS

Antigenic variants among the P3/Finland/84 strains
The five monoclonal antibodies selected for these studies were all able to neutralize the Saukett strain but unable to neutralize strain P3/Finland/23127/84, which was shown to be one of the most aberrant strains of the outbreak (Magrath et al., 1986) . As shown in Table 1 , all but one of the strains isolated from the clinical cases in the acute phase of the disease were resistant to neutralization by all five monoclonal antibodies. Monoclonal antibody 520 had a low neutralization titre (1:20) against a strain isolated from a poliomyelitis patient as reported previously (Magrath et al., 1986) . Monoclonal antibody 842 raised against the P3/Finland/23127/84 strain (Magrath et al., 1986) did not neutralize any of these strains. A human serum which had been selected because of its very low titre against the P3/Finland/23127/84 strain but a high titre against Saukett neutralized the strains from the patients very poorly (Table 1) .
Forty-three strains isolated from healthy individuals were also analysed with the antibody panel and with polyclonal rabbit and human antibodies. Characteristic patterns of neutralization were obtained for each strain. On the basis of the neutralization results obtained with monoclonal antibodies 175, 204 and 472 they were arbitrarily divided into three reaction groups ( Table 2 ). Most of the strains isolated from contacts resembled the strains from clinical cases and were not neutralized by 175,204 or the other three monoclonal antibodies at a dilution of 1:20. Titres of the type-specific rabbit antiserum varied from 1:16 to 1:256, but less variation was seen in titres of the pooled human serum and the human immunoglobulin concentrate (data not shown).
Antigenic shift in sequential poliovirus isolates from several virus exeretors
When sequential isolates from seven persons, including the index patient (A.K.) of the outbreak , were analysed, a definite change in the reaction pattern was seen in three cases (Table 3) . Although none of the monoclonal antibodies tested was able to neutralize the initial isolates from these persons, monoclonal antibody 175, and in most cases monoclonal antibody 204 as well, had high or moderate titres against one or more of the later strains. The selected human serum had a higher neutralization titre against those strains that were also neutralized by monoclonal antibody 204 (Table 3) . Table 3 ) were plaqued on monolayers of Vero cells and the plaques isolated were tested with the monoclonal antibodies indicated in a neutralization assay. These results indicated that the antigenic structure had altered in successive isolates and attempts were therefore made to re-isolate virus from the original specimens. Secondary isolates thus obtained from the specimens of patient A.K. again showed a definite change in antigenic characteristics between the second and third specimens as shown in Table 3 . However, only monoclonal antibody 175 was able to neutralize the strains isolated from the later two specimens (data not shown) although the respective initial isolates had been successfully neutralized by both 175 and 204 (Table 3) . This prompted us to study the homogeneity of the virus in the original specimens. Suspensions of faecal specimens from patient A.K. were inoculated on to monolayers of Vero cells and overlaid with an agar-containing medium. Plaques were picked from each specimen, and after freezing and thawing three times, these were tested with monoclonal antibodies 175 and 204 in neutralization assays. All plaques obtained from the two earlier specimens were identical and not neutralized by either of the monoclonal antibodies, but the two later specimens turned out to be mixtures of two variants, one of which was neutralized by monoclonal antibody 175 whereas the other was neutralized by both 175 and 204 (Table 4) . To test the hypothesis that the later variants were selected by immune pressure in the host against the former strain, a serum specimen from patient A.K., collected 2 weeks after the first isolate, was examined for neutralizing antibodies to the different variants. Similar titres (1:64 to 1:128) were found against all four sequential specimens (Table 3, A.K.) and against representatives of all three types of antigenic variant described in Table 4 .
Mutation in the region coding fbr antigenic site 1 is associated with antigenic shift
Virion RNA preparations of the above plaque-purified variants from sequential specimens of one person were sequenced at the region corresponding to major antigenic site 1 in VP 1 using the primer extension method (Evans et al., 1983) . The three antigenic variants showed single base differences between each other, resulting in corresponding amino acid changes at VP 1 positions 98 and 99 (Table 5 ). The variant neutralized by monoctonal antibody 175 had lysine substituted for asparagine at residue 98 while the strain neutralized by both monoclonal antibodies 175 and 204 had a lysine-alanine substitution for asparagine-valine at residues 98/99. DISCUSSION We have documented three aspects of the antigenic variation of wild-type poliovirus 3. First, we extended our earlier observations (Magrath et al., 1986) on the concomitant circulation of several antigenic subsets of intratypic variants during a limited outbreak of poliomyelitis in Finland. Second, we showed that the antigenic characteristics of the virus can change during replication in individual hosts and third, we demonstrated that poliovirus in a stool specimen can be a mixture of different antigenic variants.
The majority of the strains characterized were not neutralized by several monoclonal antibodies directed against antigenic site 1 of poliovirus type 3 (amino acids 89 to 100 of VP1 ; Minor et al., 1985) . Resistance to antibodies of this specificity has been rare among the previously characterized poliovirus type 3 strains .
The observations on antigenic differences between sequential isolates from individual excretors could be explained in two different ways. We could assume that the outbreak from the start was due to circulation in the population of a mixture of different variants of the antigenically aberrant poliovirus type 3, and that the apparent change in the antigenic pattern represents superinfection of the person by yet another variant. Superinfection of a person by poliovirus while still excreting a closely related strain of the same serotype is highly unlikely. The other alternative is that the variant isolates in each person are derived from the earlier isolates from the same person, i.e. a similar mutation and selective enrichment of the new variant had taken place independently in several persons during the outbreak.
A surprising feature in these observations is that the 'direction' of the change in the antigenic determinants is from a non-neutralizable to a more easily neutralizable variant when tested with monoclonal antibodies raised against the vaccine strains of poliovirus type 3. A similar increase in the ability to neutralize the later strains was observed with a selected unrelated human serum. Assuming immunological pressure in an infected person as the major selecting power in the enrichment of the new variants, these observations are unexpected. At least two explanations for this apparent discrepancy can be envisaged. First, the antigenic changes that we observed at site 1 may have taken place 'by chance' in association with putative, more relevant antigenic changes at the other known antigenic sites of poliovirus type 3, which may even be relatively more important in man . However, in one instance a serum specimen collected from the host shortly before the antigenic shift had a similar neutralization titre against all the strains. Of course, we do not know what kind of immunological pressure existed in the gut of this patient at the same time. The second possibility is that non-immunological properties associated with the antigenic change endow the mutated virus with a major growth advantage in the human gut, as compared to the original strain. Rapid enrichment of new genetic variants of poliovirus type 3 during replication in man, without obvious immunological selection pressure, has been reported previously (Nottay et aL, 1981; Evans et aL, 1985) . However, the latter hypothesis would require the additional assumption that the putative growth advantage is valid only for replication in the gut and not for transmission to another host. Otherwise the latter variants should have grown to a majority in the virus population during the early phases of the outbreak.
Our results show that, in contrast to the previous view that polioviruses are stable as regards their neutralization epitopes Almond et al., 1985) , a considerable heterogeneity in the neutralization determinants of poliovirus type 3 existed during the outbreak in Finland in 1984. Our results also indicate that the virus further evolved during the outbreak. This is a novel observation with regard to a wild-type poliovirus and it may have wider epidemiological implications.
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